Graphene oxide-modified hydroxyapatite nanocomposites in biomedical applications: A review by Hashim NC et al.
Ceramics-Silikáty 63 (4), 426-448 (2019)
www.ceramics-silikaty.cz doi: 10.13168/cs.2019.0040
426 Ceramics – Silikáty  63 (4) 426-448 (2019)
GRAPHENE OXIDE-MODIFIED HYDROXYAPATITE 
NANOCOMPOSITES IN BIOMEDICAL APPLICATIONS:
A REVIEW
NORSURIANI CHE HASHIM*, DANIEL FRANKEL**, #DARMAN NORDIN*
*Research Centre for Sustainable Process Technology, Faculty of Engineering & Built Environment,
Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia
**School of Engineering, Newcastle University, NE1 7RU, United Kingdom
#E-mail: darman@ukm.edu.my
Submitted May 16, 2019; accepted August 6, 2019
Keywords: Hydroxyapatite, Graphene oxide, Synthesis, Coating, Antibacterial, Cytotoxicity, Medical devices
Bacterial infection and cytotoxicity associated with implant materials used in medical devices are the major cause of implant 
failures. This review focusses upon the development of graphene oxide (GO) – hydroxyapatite (HA) nanocomposites as 
potential coating materials that can provide a solution to the rejection of implants. These nanocomposites combine the 
unique antibacterial properties of graphene oxide with the natural mineral composition of hydroxyapatite, as found in 
human bones and tooth enamel. They have potential antibacterial applications in the fields of orthopaedics, orthodontics 
and cardiovascular medicine. The methods used for preparation of HA and GO in addition to the combining of GO–HA 
nanocomposite are discussed. Cytotoxicity and antibacterial affects of GO and GO–HA to biological systems are examined 
as well as future applications in related fields.
INTRODUCTION
 The continuing evolution of biomedical nanotech-
nologies has enabled clinicians to recognise, prevent, 
and treat human diseases [1]. There is currently great 
interest in developing nanotechnologies that interface 
with biological materials such as cells and tissues. 
The interfacing of nano and biological materials increa-
ses the demand for in-depth understanding that enables 
vital information to be gained concerning relevant ener-
getic and biological processes [2]. An understanding of 
the propensity for nanoparticles to attach to and disrupt 
cell membranes remains an open question due to the 
heterogeneous and dynamic nature of cell membrane. 
Systematic investigations of nanoparticle-cell membra-
ne interactions can be performed using model biological 
membranes [3]. The surface nanoparticles like surface 
features and modifications are important in order to 
tune their response in contact towards biological envi-
ronments [4]. 
 Composite materials offer many advantages over 
single component systems, combining properties that 
meet the requirements of biomedical applications, for 
example orthopaedic and dentistry applications. A wide 
variety of composites have been constructed and tested 
in medical applications as a result of the seminal idea to 
design man-made composites that mimic the properties 
of natural composites [5].
 HA is a bioceramic material that is often used 
in clinical bone grafting and implantation. It is able 
to chemically bond with living bone tissue due to its 
biological and chemical composition, and its chemical 
structure which is identical to native apatite in the 
human skeleton. HA can also encourage osteoblast ad-
hesion and proliferation because of its bioactivity [6]. 
Bone tissue engineering presents a viable approach to 
repair and reconstruction of bone tissue imperfections. 
The use of biocomposite materials that mimic natural 
bone is well established [7]. Accordingly, HA is a widely-
accepted biomaterial for the repair and regeneration of 
damaged bone tissue [8].
 Nevertheless, the mechanical properties of HA still 
present a major hindrance because its low toughness 
and low flexural strength limit its use in bone system 
regeneration [5, 8-10]. Thus, second phase reinforcement 
of HA with materials such as metals, polymers and other 
organics has been developed and investigated [5, 8, 9]. 
 Importantly, HA is not able to inhibit bacterial 
adhesion, which might disturb the bone healing process 
and cause infections that lead to implant failure. About 
half of the million hospital-acquired infections per 
year in the US are associated with implanted devices. 
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An awareness of surgical site infections that are rela-
ted to implanted orthopaedic devices is necessary for 
public health due to an increasing number of aged and 
disabled patients. Bacterial infections causing biofilms 
can form on implant surfaces and are difficult to treat 
with antibiotics. Consequently, new strategies to redu-
ce bacterial activity and device-related infections 
have been developed [11]. Implantation of composites 
in living organisms can lead to biofilm formation and 
bacterial infection. Hence there is a need for implant 
surfaces that not only have excellent biocompatibility 
but also antibacterial properties [12]. 
 Multidrug resistant (MDR) pathogens have beco-
me resistant to certain antibiotics and contribute to 
problematic infections worldwide. In both the develo-
ped and the developing world, there are six pathogens 
(‘ESKAPE’ pathogens) that are most frequently found 
in hospitals and are hardest to treat. They comprise 
two Gram positive bacteria (Enterococcus faecium and 
Staphylococcus aureus) and four Gram negative bacte-
ria (Klebsiella pneumonia, Acinetobacter baumannii, 
Pseudomonas aeruginosa and Enterobacter spp.). These 
nosocomial pathogens cannot be treated by typical 
antibacterials and are resistant to the most used and 
known antibiotics. Accordingly, there is a need to find 
other mechanisms for killing pathogens in biomedical 
applications [13]. Thus the antibacterial properties of 
agents such as carbon nanotubes, metal nanoparticles 
and metal oxide nanoparticles have been explored. 
Recently, graphene has been proposed as an effective 
antibacterial material that has severe cytotoxic effects 
on bacteria, fungi and other pathogens [14]. 
 Graphene has generated substantial attention from 
researchers since 2004, due to its fascinating physical 
and chemical properties, which are widely applicable 
in biomedicine. It is considered as a strong candidate 
for an antibacterial material due to its bacterial toxicity. 
Although graphene has been successfully applied in 
biomedicine, there has been growing debate in recent 
years about the potential toxicity of graphene and its 
derivatives in biological systems at different levels of 
bacteria. In addition, the growing usage of graphene and 
its derivatives means that there is a demand for greater 
understanding of their potential adverse impacts on 
human health [15]. Coating releasing antibacterial agent 
have shown potential to decreases nosocomial infections 
[16]. 
 This review aims to offer a basic background of 
hydroxyapatite and graphene oxide and discuss some 
existing research regarding the use of graphene oxide 
to reinforce hydroxyapatite. The use of graphene 
oxide-hydroxyapatite composites as nanocoatings in 
biomedical implants could improve their antibacterial 
properties by influencing interactions with biological 
systems. Herein, GO and GO coated HA are discussed 
through in vitro and in vivo cytotoxicity as well as 
antibacterial activity towards bacterial cell membranes. 
THEORETICAL
Implant Infections
 Implant techniques have found utilization in ma-
ny areas of medicine (orthopaedics, cardiovascular, 
dentistry, traumatology and neurosurgery). Surgical 
intervention with subsequent implantation influence 
post-operative recovery, preventing inflammatory re-
sponses and of the implant rejection processes [17]. 
The crucial characteristics of well-designed implants 
include porosity, elastic biocompatibility, appropriate 
mechanical strength, low surface friction, corrosion re-
sistance, improved tribology, ability to reduce inflam-
mation and reduced bacterial adhesion to the surface. 
Global annual market for orthopaedic implant devices 
reach $30 billion by 2010 [18], $46.5 billion by 2017, 
$50 billion by 2018 and expected market of more than 
$62.6 billion by 2022. 
 Millions of people worldwide, especially those over 
50 years of age, suffer from bone and joint degenerative 
and inflammatory problems. Forecasts show that the 
number of bone disease sufferers will double by 2020. 
Worldwide millions of medical devices are used an-
nually. Orthopaedic implant devices including pros-
theses for hip, knee, ankle, shoulder and elbow joints 
and fracture fixation such as wires, pins, plates and 
screws are designed to regain the normal function of 
load-bearing joints. Metals, polymers and ceramics are 
three classes of material that are frequently applied in 
the fabrication of orthopaedic implants. As an example 
of a bioactive ceramic, hydroxyapatite acts as coating 
materials for metal implants located at femoral stems and 
acetabular metalbacks for hip joints, as well as tibial and 
femoral components for knee joints. Sources of bacterial 
infection from implants include surgical apparatus, the 
surroundings of the operating room, clothes worn by 
medical and paramedical staff and resident bacteria on 
the patient’s skin and body [19]. 
 Nosocomial infections are a major health challenge 
and are the sixth most common cause of death in deve-
loped countries. Implant rejection and repeated surgery 
are major sources of clinical problems. Improved anti-
bacterial coatings may help to meet these challenges and 
reduce the incidence of resistant bacterial infections. 
Bacteria can be attached to all instruments in the cli-
nical environment as well as to implants inserted 
into the human body. The surfaces of biomedical de-
vices should deter bacterial attachment to sustain 
stability and maintain antibacterial action in vivo. 
Accordingly, coating materials for medical devices and 
new mechanisms of antibacterial resistance have been 
developed in order to avoid microorganism adhesion and 
biofilm formation. The addition of antibacterial coatings 
can prevent bacterial colonisation as well as avoiding 
surgical complications [20].
 Orthopaedic implant-associated bacteria are chal-
lenging complications which can cause delayed healing, 
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implant loosening, implant removal, amputation or 
even death [21]. Infection in orthopaedic implants is 
one of the most common infections encountered in 
medicine. Surgical site infection is a major problem 
causing increase in non-union, osteomyelitis, implant 
failure, sepsis, multiorgan dysfunction and even death. 
Antibiotics cannot reach the bacteria in biofilms on the 
implant surface causing infections. 7 in every 132 pa-
tients developed infection, which make up 5.30 % cases 
of orthopaedic implant infection. 
 Staphylococcus aureus is the most common bac-
teria responsible for surgical site infection in orthopae-
dic implants [22] 70 % of orthopaedic implants infection 
is contribute by S. aureus and for another 8 % of 
infections by Pseudomonas Aeruginosa [23]. Gram 
negative E. coli, P. mirabilis and P. vulgaris have also 
been involved in implant-associated infection [24]. 
It was estimated that S. aureus and S. epidermidis cau-
sed about 40 - 50 % prosthetic heart valve infections 
and 50 - 70 % catheter biofilm infections [25]. Microbial 
infections are related to the colonization of pathogens 
on the surface in almost all medical devices or implants 
like orthopaedic devices, catheter (central venous, uri-
nary), respirators, prosthetic heart valves and dental 
implant (Tab. 1). Research conducted by Universiti 
Kebangsaan Malaysia Medical Centre (UKMMC), 
S. epidermidis was the prevalent Coagulase- negative 
staphylococci identified as agent of clinical infections 
in UKMMC [26]. E. faecalis attached to dentinal sur-
face was damaged (ruptured) membranes were often 
c) × 1 500
a) × 1 500
d) × 10 000
b) × 20 000
Figure 1.  SEM images of E. faecalis- infected dentine blocks treated with saline and chlorhexidine. Blocks treated with saline 
solution for 5 min demonstrate many adhering E. faecalis (a) with intact bacterial membranes (b). The group soaked with 2 % 
chlorhexidine show fewer adhering bacteria (c) and many lysed E. faecalis (d – white arrows) [29].
Table 1.  Biofilms in medical implants [27, 28].
Medical devices Microorganisms 
Contact lens P. aeruginosa, Gram positive cocci
Denture Candida spp
Urinary catheter E. coli, K. pneumoniae, Candida spp, 
 P. mirabilis, E. feacilis
Central venous catheter Coagulase-negative staphylococci, 
 S. aureus
Mechanical heart valve Coagulase- negative staphylococci, 
 S. aureus
Artificial hip prosthesis Coagulase- negative staphylococci, 
 S. aureus
Voice protheses C. albicans, Coagulase- negative 
 staphylococci
Endotracheal tubes Enteric Gram – negative species
Orthopeadic implant  Enterococci, P. mirabilis, P. aerugi- 
 nosa, E. coli, Bacteroides spp, Hemo- 
 lytic streptococci
Replacement joints S. aureus and S. epidermidis
Breast implant S. aureus, Enterococci and S. epi- 
 dermidis
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found in 5 min-soaked chlorhexidine (antimicrobial 
agent) (Figure 1). 
 Factors like differences in implant surface hydro-
philicity, surface charge, surface energy, biomaterials 
composition play a role in enhance the rate of infection 
in implants [30]. The primary bacterial adhesion to 
implant surfaces mediated by reversible interactions are 
van der Waals forces and steric- electrostatic inter-
actions. Afterwards, the bacterial cells surfaces (lipo-
polysaccharides and exopolysaccharides) adhere irre-
versibly to the substrates through hydrogen bonds, ionic 
bonding and dipole-hydrophobic interactions [27]. 
 Antibacterial coating strategies for medical devi-
ces include the release of antibacterial agent, contact-
killing (CK) and anti-adhesion (AA). In antibacterial 
agent release techniques, the coating is loaded with a 
drug which leaches out over time via diffusion, degra-
dation or hydrolysis. This release is temporary due 
to the limited reservoir of antibacterial agents. In the 
contact-killing technique, antibacterial drugs directly 
kill adhered bacteria on the surface due to their ability 
to disrupt the bacterial cell membrane. The anti-adhe-
sion (AA) technique is the earliest prevention step for 
the colonization of bacteria and biofilms using non-
cytotoxic mechanisms such as PEG and zwitterions 
[16]. All of these strategies can be achieved by GO 
containing materials. 
Hydroxyapatite ceramic coatings
 Human bone comprises 30 % organic matter (main-
ly collagen) and 70 % inorganic matter (mainly hydroxy-
apatite, HA) [9]. It can be defined as a bioceramic com-
posite, and has long drawn the attention of materials 
researchers aiming to duplicate its mechanical features 
such as high strength and fracture toughness [31]. 
 Hydroxyapatite, (HA) [Ca10 (PO4)6(OH)2] comprises 
the major part of natural bone tissue. It shows good 
bioactivity and has excellent biocompatibility with human 
tissues [32], good osteoconductivity, biodegradability, 
and is extensively applied in biomedical applications 
[33]. The ability ceramic to interact with bone tissue is a 
unique property of bioactive ceramics [34]. 
 HA has a plate like structure 20 to 80 nm long, and 
2 to 5 nm thick, with a hexagonal crystal system [5]. 
In natural bone HA is present in the form of nano-size 
crystals. Calcium and phosphorus are the fundamental 
elements in HA, with a stoichiometric ratio of 1.667 
for calcium and phosphate [8]. The packing structure 
of hydroxyapatite crystals with the chemical formula 
Ca10 (PO4)6(OH)2, and a digital photograph of a hydro-
xyapatite implant are shown in Figure 2. HA is the 
most stable form of phosphate salts under both acid and 
alkaline conditions. The high specific surface area and 
unique properties of HA allow it to be widely applied 
in orthopaedic or bone implants, as a pharmaceutical 
carrier, in anti-cancer, and anti-bacterial agents [35]. 
 It is dispersed in the human body in the form of 
its solid or ionic state, through bone resorption and 
reconstruction and metabolic processes involving cal-
cium and phosphorus ions in bone tissue. Hence, HA is 
extensively applied as artificial bones in the orthopaedic 
field for the repair of bone defects. Previous studies have 
shown that the implantation of HA in bone defects can 
improve the division and differentiation of stem cells 
due to its osteoconductive ability [9]. Osteoconductive 
interactions with HA lead to bone bonding and 
regeneration [10]. 
 Currently, many HA composites with organic ma- 
terials are being developed, for example synthetic and 
natural polymers with good biocompatibility, antibac-
terial activity and will induced osteogenesis [9], and 
bio-active, non-inflammatory and non-immunogenic 
properties [8]. The high specific surface area of the rod-
like HA structure can provide better protein absorbability 
and thus good biocompatibility and bioactivity [10]. 
Biocompatibility is described as chemical stability, re-
sistance to corrosion, noncarcinogenicity and nontoxi-
city when a material is implanted in the human body [5]. 
 Synthetic HA nano powder has been demonstra-
ted as a coating material in orthopaedic and dental 
implants. HA coatings have good potential due to their 
biocompatible and bone-like ceramic properties. Ortho-
paedic implants have been successful due to a focus on 
improving the mechanical and biological properties of 
HA coatings with bionanotechnology. The quality of the 
coating is influenced by the synthesis process of the HA 
powder, which influences important factors such as the 
phase composition, purity, crystallinity, particle size, 
particle-size distribution, specific surface area, density 
and surface morphology. The HA Ca/P ratio of 1.52 - 2.0 
makes it a superior choice in dental and orthopaedic 
bioceramic coating applications [36]. Figure 2 shows the 
structure and implant of HA. 
DISCUSSION
In situ synthesis of HA
 To date, many diverse methods have been publi-
shed for the preparation of HA nanoparticles, while 
growing interest in the manufacture of HA means that 
 a) b)
Figure 2.  Packaging structure of hydroxyapatite crystal with 
the chemical formula Ca10 (PO4)6(OH)2 (a) and digital photo of 
hydroxyapatite implant (b) [17].
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new preparation methods continue to be developed 
[37]. In recent years, methods applied to HA synthesis 
have included precipitation techniques [38], sol-gel ap-
proaches, and hydrothermal, multiple emulsion, biomi-
metic deposition and electrodeposition techniques [39] 
and polymeric sponge template [40]. 
Wet chemical synthesis
 Wet chemical methods are aqueous methods that 
involve the synthesis of HA where the final products 
gained are characterised by a high degree of crystal-
lisation and high purity. These properties depend on 
the conditions of synthesis such as the temperature, 
the starting concentration of the reactants, the pH envi-
ronment, the acid addition rate, the stirring speed and 
the thermal treatment conditions applied to the dried 
HA powders (Figure 3) [8]. 
 This technique is widely used and is the most popu-
lar technique for the practical and economical synthesis 
of HA in large amounts at low reaction temperatures, 
with microstructure properties in the final product and 
no harmful by-products [39, 41]. Moreover, this tech-
nique is one of the easiest ways to prepare HA powders. 
It was first proposed by Yagai and Aoki, using calcium 
hydroxide (Ca (OH)2) and orthophosphoric acid (H3PO4) 
as the starting materials [42]. The precipitation reaction 
is shown in chemical Equations 1 and 2.
CaO+ H2O → Ca (OH)2                (1) [43] 
            10 Ca (OH)2 + 6 H3PO4 →
            → Ca10 (PO4)6 (OH)2 + 18 H2O            
(2) [43]
Sol-gel technique
 A sol-gel process is a process in which a sol (colloidal 
suspension of solid particles) is transformed into a 3D 
network in the solid phase. In this technique precursors 
are mixed, then aged, gelated, dried and calcinated to 
remove remaining organic material [12]. The sol-gel 
is preferred because of its low synthesis temperature, 
high product purity, homogenous molecular mixing 
and ability to produce nano-sized particles [44] It also 
has the flexibility to produce nanocrystalline powders, 
bulk amorphous monolithic solids and thin films. 
Additionally, it is easily applied to surface coating and 
can be used in the preparation of high quality HA films 
on metal substrates [45]. 
 Furthermore, the method does not require pH con-
trol, high temperature or vigorous agitation. The crys-
tallinity of HA decreases with decreasing temperature. 
As a result, using the technique at lower temperatures 
might be time consuming, expensive and complicated 
[46]. The sol-gel HA reaction is shown in Equation 3 
and Figure 4.
         6Ca(NO3)2 + 6(C2H5O)3P(O) →
       → Ca10 (PO4)6 (OH)2 + by-products
        (3) [37]
Hydrothermal technique
 The hydrothermal process is a chemical reaction 
process in aqueous solution that takes place at higher 
temperatures and pressures. It can also be classified 
as a chemical precipitation in which the aging step is 
operated at temperature above the boiling point of 
water, inside an autoclave or pressure vessel. Increasing 
the hydrothermal temperature can improve the phase 
purity and Ca/P ratio of HA. However, the hydrothermal 
process is more expensive than other wet methods 
due to the expensive equipment required for the high 
temperature and pressure reaction [37]. The preparation 
of rod like HA via the hydrothermal technique is shown 
in Figure 5. 
 The different wet methods for the preparation of 
HA are compared and summarised in Table 2.
Figure 3.  Graphical representation of the wet chemical syn-
thesis of HA [8].
Figure 4.  Synthesis of HA by the sol-gel technique [37].
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Graphene oxide
antibacterial coatings
 One of the approaches to biomaterials surface 
resistant to biofilm is bactericidal or bacteriostatic 
coatings to the surface [25]. Two main characteristics 
needing of these coatings. Firstly, necessary to avoid 
bacterial attachment and resistance to bacteria develop-
ment. Secondly, coatings should guarantee long-term 
applications [20]. 
 Graphene is a two-dimensional (2D) nanomaterial 
comprising a monolayer of carbon atoms [47] arranged in 
a flat honeycomb lattice [48]. It is pristine and arranged in 
a sp2 bonded aromatic structure [49]. Graphene is one of 
the allotropes (carbon nanotube, fullerene, diamond) of 
carbon, with a carbon-carbon bond length of 0.142 nm, 
its electrons behave like massless relativistic particles 
[50].
 These single-atom-thick, hexagonally arranged car-
bon atoms in two dimensional sheets, first discovered 
in 2004, have been the subject of an explosion of new 
research, and led to the Nobel Prize in 2010. In 2010, 
the number of published scientific papers on graphene 
exceeded 3000 in a single year and worldwide, there are 
a growing the number of companies that manufacture 
graphene products although most are primarily doing 
research and development [51]. Quantitative analysis of 
scientific data (Figure 6) shows that the used of graphene 
materials as antibacterial compound became interest in 
the last few years. 
 Reports indicate that in 2020 the market projection 
of graphene based products will reach $675 million 
[52]. Scientists have eagerly embraced graphene as it is 
a lighter and cheaper alternative to existing metal con-
ductors [50]. Benefits of GO include low cost, accessi-
bility and the ability to alter graphene [17].
 Graphene has extraordinary physical, chemical, 
mechanical [32] and optical properties [47]. The unique 
properties of graphene are shown in Table 3. 
 Its high specific surface area is a major benefit in 
the high-density bio-functionalisation that is fundamen-
tal to drug delivery [54]. The theoretical specific surface 
area of graphene sheets is 2630 m2∙g-1, much larger than 
the latest reported carbon black, at 900 m2∙g-1, while 
Figure 5.  Preparation of rod like HA via the hydrothermal technique [37].
Table 2.  Comparison of different wet methods for HA preparation. Modified from [46].
Characteristics/ Chemical precipitation Sol-gel HydrothermalMethod
Cost Low Variable Generally high
Morphology Diverse Diverse Frequently needle-like
Crystallinity Frequently low Generally low Very high
Phase Purity Variable Variable Generally high
Ca/P ratio Non-stoichiometric Stoichiometric Stoichiometric
Size Generally nano Nano Nano or micro
20
10
91
2
9
15
95
41
26
09
65
42
22
12
8
57
40
18
4
75
52
27
3
97
22
44
5
12
84
2
74
5
15
34
0
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3
16
54
7
11
61
20
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20
14
20
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20
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20
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Figure 6.  Publications on GO and its antibacterial interactions 
based on the number of articles in the “Sciencedirect” database 
from the year 2010 to August 2019.
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carbon nanotubes (CNTs) have a surface area of about 
100 to 1000 m2∙g-1. Its larger surface area combined with 
other high performance properties has contributed to its 
use in energy applications, for instance in transparent 
conductive electrodes for solar cells, high capacity elec-
trodes in lithium-ion batteries and supercapacitors, and 
in hydrogen storage [55]. 
 The layered structure of GO is similar to graphene, 
but GO carbon atom planes contain oxygen groups, 
resulting in expansion of the interlayer distance and 
making the hydrophilic atomic layer thicker. The GO 
sheet structure is known to contain functional oxygen 
groups including C–O, C=O and –OH, which act as 
a support on the surface of a graphene monolayer 
(Figure 7). Existence of oxygen-containing groups 
brings about the stronger hydrophilic properties of GO, 
as well as allowing dispersion in some solvents, such as 
water [56]. In other words, it has hydrophilic character, 
and water molecules can easily intercalate between 
the graphite layers. GO acts as a 2D amphiphile with 
hydrophilic carboxyl groups at the edges and hydropho-
bic epoxy, hydroxyl and graphitic domains on its ba-
sal plane [57]. GO surfaces are capable of hydrogen 
bonding and metal ion complexation due to partially 
hydrophobic and hydrophilic regions, and negatively 
charged carboxylate groups at edges or defect sites. 
 The presence of plentiful carbonyl, epoxide and 
hydroxyl groups in GO provides large numbers of 
chemically reactive sites. GO also offers advantageous 
mechanical properties, high hydrophilicity and good bio-
compatibility that could make it a promising nanoscale 
reinforcement filler in biocomposites that can increase 
interfacial bonding among the components [32]. 
 The main function for GO hybrid is to enhance the 
composite mechanically. GO is frequently used in HA 
biomimetic synthesis due to its lack of toxicity to cells 
and the high mechanical strength of graphene-based 
composites [35]. Improved mechanical function could 
be observed in Table 4. 
 GO has been used in a wide range of applications 
such as cell imaging, drug delivery and gas separation 
membranes [47], antibacterial treatments [67], adsorbent 
materials [68], tissue engineering [69] and filler in po-
lymer membrane [70]. Other engineering applications 
have emerged due to research into graphene properties 
including uses in structural composites, conducting po-
lymers, antibacterial papers and biomedical technologies 
[51]. Figure 8 presents the overall application graphene-
based have been investigated for biomedical applications. 
non-medical and medical applications [71].
Table 3.  The unique properties of graphene [53].
  Properties of graphene
 i. the thinnest material
 ii. the strongest and stiffest material
 iii. nearly transparent
 iv. the most stretchable crystal
 v. high thermal conductivity
 vi. the highest current density at room temperature
 vii. being entirely impermeable
 viii. the highest intrinsic mobility (100 times more than Si)
 ix. conducting electricity with no electron limit
 x. having a large surface area
 xi. the longest mean free path at room temperature
Table 4.  Improved mechanical function by GO hybrid.
GO hybrid References
GO/HA/PVA [58]
GO/HA/PLA [59]
GO/HA/chitosan (CS) [9]
GO/polycaprolactone (PCL) [60]
GO/HA [39]
GO/HA/ sodium alginate (SA) [61]
GO/HA [62]
GO/HA/CS [63]
GO/HA/PLA [41]
GO/PLGA [64]
GO/starch [65]
GO/epoxy [66]
O
O
O
OH
OH
OH
OH
OHOH
HOOC
HOOC
COOH
COOH
b) graphene oxide (GO)
a) single graphene sheet
Figure 7.  Schematic structure of: a) a single graphene sheet; 
b) graphene oxide (GO) [56].
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Production of GO
Modified Hummers method
 The synthesis of graphene involves exfoliation and 
cleavage, chemical vapour deposition (CVD), thermal 
decomposition and electrochemical reduction. Attractive 
methods of preparation that have been used in recent 
years are graphite oxidation, GO aqueous dispersion 
and GO reduction [72]. However, the above methods 
are less effective in large scale manufacture because 
they produce very low yields and cannot achieve high-
quality on the industrial scale [73]. Hummer’s method is 
the most popular technique used by researchers [72].
 GO is graphite that has been oxidised together with 
oxygen molecules in carbon layers. The interplanar 
spacing between the layers of graphite is increased 
when oxidising agents react with graphite [74]. The 
first synthesis of GO was demonstrated by Brodie in 
1859, adding a sample of potassium chlorate to a slurry 
of graphite in fuming nitric acid. The improvement by 
Staudenmaier in 1898 used a mixture of concentrated 
sulphuric acid and fuming nitric acid and continued with 
the dual addition of chlorate to the reaction mixture, 
resulting in highly oxidised GO. In 1958, Hummer 
reported an alternative method to synthesise graphene 
oxide by using KMnO4 and NaNO3 in concentrated 
H2SO4 [56, 75]. 
GO-HA nanocomposite coating
 Like other composite system, homogenization of 
second phase reinforcement is crucial to the performance 
of GO-HA. There are two main goals during composite 
preparation when combining HA and GO. First is to 
create homogenous dispersion of HA coated on GO, 
ensuring uniform properties throughout the composite. 
Second to encourage interaction between the HA and 
GO. The well mixing and blend allow composite can 
disperse easily and can improve interfacial bonding. 
Figure 9 present the classification of different powder 
or precursor processing technique reported for GO-HA 
system. 
Figure 8.  Graphene and graphene oxide (GO): Various non-medical and medical applications [71].
Composite Powder/Precursor
Chemical method
Sol-gel
Hydrothermal
Ultrasonication
Probe sonication
Electrochemical
deposition
Wet chemical
precipitaton
Mechanical
agitation (Stirring)
Mechanical mixing
Figure 9.  Classification of techniques adopted for composite 
powder or precursor of GO–HA.
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Composite interaction
 The interaction of GO and HA is an electrostatic 
interaction. Abundant amounts of oxygen functional 
groups such as carboxylic acids as well as phenolic 
hydroxyls on GO surface and edges make GO highly 
negatively charged. Electrostatic interactions between 
GO-HA occurred when the negatively charged GO can 
absorb the positively charged calcium atoms (C sites) 
in (100) crystal plane of HA. After compositing, the 
positively charged calcium cations would be adsorbed the 
negatively charged of GO through electrostatic charged, 
as shown in Figure 10. Previous studies proved that GO 
could form strong interface bonding with positively 
charged bioceramic. Recently GO has been used to 
absorb some organic chemicals containing benzene 
rings or pyridine such as polystyrene, polyaniline, 
DNA, porphyrin through π-π stacking interaction and 
absorbing some cations inorganic particles such as 
Ag3PO4, ZnO and Al2O3 through electrostatic interaction 
[76]. 
 HA nanoparticles can be prepared with graphene 
nanosheets through spark plasma sintering (SPS) pro- 
cess, bioinspired mineralization, biomimetic mineraliza-
tion, in situ chemical precipitation reaction, simple pre-
cipitation and hydrothermal method [77], radio frequen-
cy chemical vapour deposition (RF-CVD) technique. 
All these techniques were promising in-vitro bioactivity, 
however all these fabricating methods are complicated 
and time consuming comparing with in-situ synthesis. 
In-situ synthesis employed more facile, economical and 
effective process in producing GO-based HA nanocom-
posite, yet better distribution and strong interfacial 
bonding of HA towards GO nanosheets [63]. 
 To date, there are methods on the formation of 
GO-HA composites that have been reported. There are 
a number of approaches to synthesis of GO-HA such as 
mechanical mixing method, wet chemical precipitation 
method, sol-gel method, hydrothermal method electro-
chemical deposition method / electrophoretic (EPD) 
method and ultrasonic-assisted method. 
 The mechanical method involves physical mixing 
of HA dispersed onto a GO surface using a magnetic 
stirrer and electrospinning devices by applying mecha-
nical forces. Mechanical mixing takes a long duration 
and can be augmented by chemical mixing to enhance 
HA dispersion on GO. Several methods can be used to 
disperse HA in the matrix for example physical blending 
and mixing. GO-HA was prepared by the wet chemical 
precipitation method [7, 59, 78]. Composite GO-HA has 
the potential to act as a osteoconductive composite to 
support adhesion of osteoblast cells with good viability. 
The GO-HA composite functions well with a high via-
bility of osteoblast cells compared to uncoated GO 
nanoparticles. Surface functionalization of GO by HA 
increases cell attachment and prolifera-tion in order to 
enhance bone formation [7]. 
 HA filled on the GO surface, indicating a strong 
interaction between HA nanoparticles and GO films. In 
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Figure 10.  Schematic illustration interaction of GO–HA composite.
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addition, nanoparticles of HA prevent GO films from 
agglomeration and enhances electricity properties of 
GO films. GO-HA nanocomposite can be potential 
candidate for biosensor and catalytic application [78]. 
 While preparing GO-HA using research methods 
activity by Raucci, M et al. 2016 [32] were in-situ sol gel 
and biomimetic method. Sol-gel technology which is a 
simple, economical and effective approaches formation 
of hybrid material based on nano-HA embedded in GO 
sheet. Sol-gel method was produced in gel water due 
to hydrophilicity and the electrostatic repulsion of GO 
[79]. This material is a promising biomedical coating for 
bone implant other surgery applications [58]. 
 Zhou et al. 2017 [80] and Ramadas et al. 2017 [77] 
has succeeded in preparing GO-HA composites via 
a hydrothermal method. Similarly work carried out by 
Yao et al. 2016 [35] which hydrothermally treated served 
as drug carriers. GO/HA nanocomposites treated by 
hydrothermal not only highly biocompatible but also 
mechanical improved features and applying in implant 
biomaterials [81]. 
 Electrochemical deposition or electrophoretic de-
position (EPD) is a ceramic production by colloidal pro-
cess that suitable for preparing cost-effective coatings 
on substrates with complex geometry. This technique 
used by powder particles suspended in a liquid medium 
which attracted and deposited onto a conductive sub-
strate of opposite charge. It is a widely used coating 
technique for ceramics as well as biomaterials [82]. 
Work performed by Zeng et al. 2016 [39] and Li et al. 
a)
a) GO
b)
b) HA
Figure 11B.  TEM micrographs of GO, HA, GO-HA composite suggesting good dispersion of HA in GO by sol-gel method [32]. 
(Continue on next page)
Figure 11A.  TEM micrographs of GO, HA, GO-HA composite suggesting good dispersion of HA in GO by wet chemical preci-
pitation [59].
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Figure 11C.  TEM micrographs of GO, HA,  GO-HA composite suggesting good dispersion of HA in GO by hydrothermal [80]. 
(Continue on next page)
e) GO-HA 2 % f) GO-HA 2 %
Figure 11B.  TEM micrographs of GO, HA, GO-HA composite suggesting good dispersion of HA in GO by sol-gel method [32].
c) GO-HA 1 % d) GO-HA 1.5 %
a) b)
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2014 [63] involved the synthesis of GO-HA composite 
coatings using electrochemical deposition methods 
suggested that GO-HA composites could be promising 
candidates for implants coatings.
 Regarding to works by Radha et al. 2017, facilitates 
the stable interfacial nanocomposites between GO-HA 
and promotes cell proliferation. GO-HA nanocomposi-
te was prepared through probe sonication process by 
functionalizing the HA onto the GO surface which 
would increases the mechanical, biostability and com-
patibility of GO-HA nanocomposite [83]. The amount 
of spherical HA in composites was decreased as in-
crease weight percentage of GO, and the folds on GO 
surface were multiplied. An irregular wrinkles surface 
facilitates mechanical lock and increase stress transfer 
of GO-HA. This non-toxic and biocompatible composi-
te demonstrated the osseointegration ability and good 
proliferation for bone replacement or repair materials 
[84]. Nanorod HA/GO composite synthesis by ultraso-
nic and biomimetic mineralization is a GO-based, free 
template, non-toxic and bioactive composite that may be 
applied as bone replacement materials [85]. Figure 11 
shows TEM images of the successful preparation of 
GO-HA composite by different technique approaches 
and Table 5 presents the summary of preparation 
GO-HA and their related applications. 
Antibacterial and cytotoxicity effects
GO
 The antibacterial activity of graphene has both 
physical and chemical effects. Physical damage can be 
induced by direct contact of sharp graphene edges with 
Figure 11D.  TEM micrographs of GO, HA, GO-HA composite suggesting good dispersion of HA in GO by electrochemical depo-
sition [39].
Figure 11C.  TEM micrographs of GO, HA,  GO-HA composite suggesting good dispersion of HA in GO by hydrothermal [80].
c) d)
a) GO b) HA
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bacterial cell membranes and destructive extraction of 
lipid molecules. Physical damage by sharp edges of gra- 
phene is highlighted among the mechanisms of the 
antibacterial activity of graphene. The density of these 
edges is considered to be one of the key factors in anti-
bacterial activity, because the sharp edges can puncture 
the bacterial cell membrane forming pores and leading 
to osmotic imbalance and bacterial death. The chemical 
effects primarily involve oxidative stress created by 
reactive oxygen species (ROS) or charge transfer [86]. 
 Mechanisms of cytotoxicity are still under dis-
cussion and investigation due to the finding that GO 
exhibits toxic effects on gram-positive and negative 
bacteria and on human cells. Further clarification of 
GO cytotoxicity is required to ensure the safe design of 
GO-based materials. Previous studies suggest that GO 
cytotoxicity mechanisms include the destruction lipid 
bilayers, oxidative stress, inhibition of cell proliferation 
and penetration of lipid membranes by edges and corners 
of GO nanosheets [47].
 Studies have shown strong antibacterial activity for 
graphene and GO, and severe cytotoxicity to bacteria, 
for example in Escherichia coli. The direct interaction 
of graphene and bacterial cell membranes arising from 
graphene induced cytotoxicity results in serious phy-
sical damage to cell membranes. However, toxicity is 
a)
c)
b)
d)
Figure 11E.  TEM micrographs of GO, HA, GO-HA composite suggesting good dispersion of HA in GO by ultrasonic-assisted 
[85].
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reduced when nanosheets are surrounded by proteins. 
According to Bianco, recent studies concerning the 
toxicity of graphene and its derivatives, including in 
vitro and in vivo studies, clearly show that there are no 
specific risks, while others argue that there might be 
health hazards. Other reviews state that the toxicity of 
graphene towards different microorganisms, cells and 
animals, is influenced by its physicochemical properties 
including surface functional groups, size, charge, and 
coatings. Structural deficiencies may alter its behaviour 
and also its toxicity in biological systems [54]. 
 Accordingly, larger sized GO sheets showed stron-
ger antibacterial activity due to their ability to completely 
cover bacteria, block their active sites and decrease their 
viability. In comparison, smaller sized GO had weaker 
antibacterial activity due to adhesion of GO only at the 
bacterial surface, without efficiently isolation from the 
environment. In addition, the antibacterial activity of 
graphene is influenced by the time of exposure and the 
concentration. Higher GO concentrations led increased 
antibacterial activity [86].
 An exploration of the antibacterial properties of 
GO interacting with Gram-negative bacteria (E. coli) by 
Huang and co-workers in 2010 stated that GO damaged 
cell membranes and restrain the growth of E. coli. 
Further studies using Gram-negative E. coli and Gram-
positive S. aureus as model bacteria have demonstrated 
the bacterial toxicity of GO and rGO nanowalls. GO and 
rGO deposited on stainless steel substrates damaged cell 
membranes through direct contact with the very sharp 
edges of the nanowalls [15]
 GO had the strongest antibacterial activity followed 
by rGO, graphite and graphite oxide [15, 48, 52] at the 
same concentrations and under the same incubation 
conditions. However, some controversial studies suggest 
GO may lack antibacterial activity. There is some evi-
dence suggesting that GO has neither antibacterial 
activity nor cytotoxicity properties. Hence, careful stu-
dies to understanding the toxicity of graphene-based 
materials are still required [15]. Table 6 presents the 
mechanisms and effects of GO interacting with Gram 
positive and Gram-negative bacterial cells. 
 Nguyen et al. 2015 [87] investigated the antibac-
terial activity of GO against human intestinal bacteria 
and in vitro cytotoxicity of GO using the Caco-2 cell 
line derived from a colon carcinoma. The results exhi-
bited no toxicity against E. coli, L. acidophilus and 
B. animalis at different concentrations (10-500 μg ml-1) 
and mild cytotoxicity towards Caco-2 cell line after 24 h 
exposure suggest it biocompatibility. Besides, in view of 
GO oxidation degree related to their toxicity. According 
to Zhang et al. 2015 [88], the cytotoxicity of three GO 
samples with different oxidation degrees on mouse 
embryo fibroblasts (MEFs), found that the decreased 
Table 5.  Techniques for the preparation of GO-HA composite and their related properties.
Technique Composite Application Biocompatibility Ref.
 
GO/HA/Cellulose Scaffolds of bone defects
 MG-63 and [7]   NIH-3T3 cells
Wet chemical precipitation PLA/HA/GO Load-bearing           – [59]  orthopedic implants
 GO/HA Biosensor and catalytic           – [78]
 GO/HA Bone tissue engineering Human mesenchymal [32]
Sol-gel
   stem cell (hMSC)
 HA/GO/PVA Coating of bone implants           – [58]
 GO/HA Bone regeneration           – [79]
 PCL/HA/Graphene Biomedical           – [80]
 GO/HA Drug delivery, orthopedic Human skin cancer [77]Hydrothermal  and dentistry cells (A431)
 GO/HA Implant biomaterials NIH-3T3 cells [81]
 GO/HA Drug delivery           – [35]
 GO/HA Coating of implants MG-63 [39]
   Murine fibroblast
Electrochemical deposition Chitosan/GO/HA Bone repair, bone augmentation, (L-929 cell line) [63]  coating of biomedical implants and human osteoblast
   (MG-63 cell line)
 GO/HA Cell proliferation Erythrocytes [83]
 GO/HA Bone replacement MC3T3-E1 cells [84]Ultrasonic- assisted  or repair materials
 GO/HA Bone substitution Mouse embryonic [85]   osteoblast (MC3T3-E1)
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in oxidation degree GO exhibited a higher degree of 
cytotoxicity and apoptosis. 
 The studies on GO dose-dependent toxicity to 
cells and animals, Wang et al. 2011 [89] evaluated 
the toxicity of GO against human fibroblast cells and 
mice. The result showed that the low dose of GO less 
than 20 μg∙ml-1 did not exhibit toxicity towards human 
fibroblast cells, while the high dose of GO more that 
50 μg∙ml-1 exhibit clearly cytotoxicity which cause de-
creasing cell adhesion, inducing cell apoptosis, entering 
into lysosomes, mitochondrion, endoplasm and nucleus. 
Similarly, in vivo cytotoxicity towards mice indicated 
no cytotoxicity with low dose and middle dose, 0.1 and 
0.25 mg respectively, while high dose of GO, chronic 
toxicity for high doses of GO, 0.4 mg affecting mice 
death, lung granuloma formation mainly located in 
lung, liver, spleen and kidney. 
 Similarly, Chang et al. 2011 [90] concluded that no 
obvious cytotoxicity of GO towards A549 cells because 
GO do not enter A549 cells, but cause a dose-dependent 
oxidative stress in cell and high concentration slightly 
loss cell viability. Other studies of GO cytotoxicity by 
various sizes and oxygen content have been investigated 
in human erythrocytes and skin fibroblasts through in 
vitro hemolysis and WST-8 viability assays. The results 
demonstrated that all GO was dose-dependent hemolytic 
activity on RBCs. Sonicated (smaller), individual GO 
sheets showed higher hemolytic activity despite of non-
sonicated (larger) and aggregated sheets [91]. 
 In addition, Hu et al. 2011 [92] demonstrated the 
cytotoxicity studies of GO on A549 cells affecting fetal 
bovine serum (FBS) and formation of a protein corona 
. The concentration-dependent cytotoxicity showed that 
the sensitivity of human cells at low concentrations of 
FBS (1 %) and the presence of 10 % FBS in cell media 
reduced the GO cytotoxicity. The cytotoxicity of GO 
arises from the direct physical contact GO towards 
plasma membranes. The observations suggested that 
FBS-mitigate GO cytotoxicity as an alternative and 
convenient route for safe biomedical and environmental 
applications.
 J. Wu et al. 2015 [93] investigated the potential in 
vitro cytotoxicity of GO against model human breast 
cancer MDA-MB-231 cell line. The result of high 
concentration of GO (≥ 100 μg∙ml-1) in a significant 
time and dose-dependent demonstrated the suppression 
colony-formation capacity and cellular proliferation as 
well as the generation of intracellular ROS by oxidative 
stress. Oxidative stress is the possible anti-breast cancer 
mechanisms induced by cytotoxicity of GO towards 
MDA-MB-231 cell. In vitro toxicity studies in cell lines 
included generation of reactive oxygen species (ROS), 
inflammatory responses, DNA-damage and oxidative 
proteins damage [94]. 
 The toxicity study on male rat was exposed to GO 
via tail vein injection with varied GO concentration for 
7 days resulted to the lung, liver and spleen inflamma-
tions. This study indicated that the low concentration 
level of GO is nontoxic [95]. In vivo cytotoxicity study 
of GO towards Japanese white rabbits via intravitreally 
injection of GO into rabbits’ eyes, indicated that few 
changes in eyeball appearance, intraocular pressure 
(IOP), eyesight and histological examination [96]. 
 Plus, in lines of dental and periodontal diseases, 
He et al. 2015 [97] revealed that the antimicrobial affects 
of GO nanosheets against dental pathogen is predomi-
nant. GO suppress the growth and viability of dental pa-
thogens (Streptococcus mutans, Porphyromonas gin- 
giyalis and Fusobacterium nucleatum) as well as de-
stroy their cell wall and membrane cell and leak out 
(Figure 12A). Thus, GO is superior candidate in dental care 
application. In addition, they observed that GO con-
centration in the range 50 - 100 μg∙ml-1 keeps the balance 
between minor cytotoxic effects and major antibacterial 
activity [98]. Figure 12B presents the TEM images of 
cell morphology of E. coli bacteria that were incubated 
with 100 mg∙ml-1 GO nanosheets at 37 ºC. Three have 
three stages (I, II and III) and two types (Type A and 
Type B) molecular mechanisms of E. coli morphology 
were observed during 2.5 h incubation process [99]. 
 According to Shubha et al. 2016 [100], the study 
of antimicrobial surface against nosocomial pathogens 
(Streptococcus aureus and Pseudomonas aeruginosa) 
for surface disinfectant purposes clearly revealed that 
GO successfully inhibited the nosocomial pathogen 
and perturbed bacterial membrane. Hence, this result 
suggested GO successfully can be applied as coating 
over hard surfaces in hospital set-up. Zone of inhibition 
is larger for the high concentration of GO [101]. 
Table 6.  Mechanisms and effects of GO interacting with Gram positive and Gram negative bacterial cells [13].
 GO interaction with bacteria  Gram positive
                            Mechanism   Effect                      
and/or Gram negative bacteria
Physical contact interaction- entrapment of bacteria Cell death Gram negative
Cell membrane damage, efflux of cytoplasmic materials, Cell death Gram positive, decreasing metabolism   Gram negative
ROS production, glutathione loss, oxidative stress Cell death Gram positive, 
   Gram negative
Adhesion of the bacterial cell to the graphene surface,  Cell growth,  
proliferation and stimulation of biofilm formation GO reduction Gram negative
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 Besides of antibacterial and toxicity of GO, GO 
also work in antiviral properties. An investigation done 
by Ye et al. 2015 [102] revealed that GO inactivated 
pseudorabies virus (PRV, a DNA virus) and porcine 
edidemic diarrhea virus (PEDV, an RNA virus) by 
structural destruction before entry into cells. 
 The study conducted by Ma et al. 2018 [103] inves-
tigated the interaction of GO with ubiquitin-proteasome 
system, found that GO-induced the inhibition activity of 
both purified 20S proteasome and proteasome in living 
cells. Computational techniques also demonstrated the 
blockage of central gate in the α-subunits for entry 
Figure 12A.  TEM images of S. mutans, P. gingiyalis and F. nucleatum cells after incubation with 80 μl GO nanosheets dispersion 
(right side) 2 h and after incubation with saline solution for 2 h as control (left side) [97].
c) P. gingivalis
b) F. nucleatum
a) S. mutants
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and exit of proteasome to active site of protease. The 
findings promote GO as future oncologic therapeutics 
applications. 
 In contrarily, S. Wu et al. 2014 [104] proved that 
low cytotoxicity of GO and did not affect the antitu- 
mor activity of doxorubicin (DOX) against human mul-
tiple myeloma cells (RPMI-8226). GO did not induce 
cell apoptosis and inhibited cell proliferation. The 
results suggest that GO is suitable for anticancer drug 
nanocarrier and hematological malignancies treatment. 
 GO could induce in vitro apoptosis of erythroid 
cells through oxidative stress in E14.5 fetal liver ery-
throid and in vivo GO-declined erythroid population in 
spleen led to erythropoiesis disordered in mice [105]. 
GO-HA nanocomposite
 Toxicity and biocompatibility are major concerns in 
biomedical materials. Cytotoxicity assays are methods 
to analyze the biocompatibility of prepared nanocom-
posite to determine whether it can be toxic or harmful 
towards living organisms. According to Ramadas et al. 
2017 [77] GO-HA nanocomposite showed no toxicity 
effects on the human skin cancer cell line (A431) using 
MTT assays. This confirmed GO-HA to have excellent 
biocompatibility and to be a potential biomaterial for 
orthopedic, drug delivery and dentistry applications. 
 Antibacterial tests of electrodeposited GO on 
HA-P-ATi revealed toxicity towards both Gram-posi-
tive and Gram-negative models. It was found to be 
more toxic towards Gram-positive bacteria (S. aureus 
bacteria) compared to Gram-negative bacteria (E. coli 
bacteria). Membrane damage of bacteria was implemen-
ted by exposing bacteria to phosphate buffer solution. 
Membrane damage was caused by increasing GO con-
centrations through direct contact interaction. GO edges 
(good acceptors) causes membrane damage of bacteria. 
S. aureus less resistant to the GO damaging due to 
thicker peptidoglycan layer of Gram-positive bacteria 
Figure 12B.  TEM images of E. coli exposed to GO nanosheets; a) – f) showing E. coli undergoing changes in morphology after 
incubation with 100 μg∙ml-1 GO nanosheets at 37 ºC for 2.5 h. Three stages of destruction can be seen: a) Initial morphology of E. 
coli (control or Stage 1, two individual TEM images (inset and main page) are shown; b) and c) Partial damage of cell membranes 
with some bacteria showing lower density of surface phospholipids (Stage II). Arrows indicate Type B mechanisms, where 
graphene nanosheets extract phospholipids from the cell membrane: d) – f) Three representative images showing the complete 
loss of membrane integrity with some demonstrated ‘empty nests’ and missing cytoplasm (Stage III); d), f) Representative images 
showing Type A mechanisms, where graphene nanosheets cut off large areas of membrane surfaces [99].
 a) b) c)
 e) f) g)
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(20 - 80 nm) compared to E. coli, Gram-negative bac-
teria (7 - 8 nm). Nanocomposite GO-HA can reduce 
bacteria susceptibility for S. aureus and E. coli, hence 
it is potential antibacterial nanocomposite to restrain 
bacteria for orthopedic implants [31]. 
 The preparation nanocomposite by in vitro cyto-
toxicity was investigated by using CCK-8 assay on the 
murine fibroblast L-929 cell line and human osteoblast-
like MG-63 cell line. The result after incubation for 
5 days was shown that the prepared nanocomposite 
induced no in-vitro cytotoxicity towards L-929 cell 
and MG-63 and had no time for cytotoxicity. GO-
based HA provide new prospects to bone repair, bone 
augmentation, and biomedical implant coating [63]. 
 According to Surendran et al. 2017, in-vitro anti-
bacterial assay of GO-HA nanocomposite was carried 
out by agar well diffusion method against Gram-po- 
sitive Enterococcus faecalis and Gram-negative Pseu-
domonas aeruginosa bacteria. As the result show that 
the antibacterial revealed GO-HA nanocomposite 
inhibited Enterococcus faecalis for 6, 10 and 12 mm and 
Pseudomonas aeruginosa for 2, 4 and 8 mm diameter 
inhibition zones for concentration 25, 50 and 75 μg∙ml-1 
respectively. Thus, it is can be good candidate for bio-
medical application especially in orthopedics [106]. 
 The inhibitory zone by agar disc diffusion method 
(at 37 °C for 24 h) of 10 wt. % PCL/HA/GO composite at 
different doses (25, 50, 75 and 100 μl) against S. aureus 
was 10, 11, 14, 16 mm and E. coli was 10.5, 12, 14.5, 
16.5 and 20.5 mm, respectively [107]. A good in vitro 
antibacterial ability by SiO2-GO-HA composite against 
E. coli and S. aureus using agar well diffusion method 
[108]. The results of in vitro antibacterial activity were 
shown in Figure 13.
CONCLUSION
Research highlights
● The GO-HA combination was successfully carried 
out by different approach including wet chemical 
precipitation method, sol-gel method, hydrothermal 
method electrochemical deposition method/ electro-
phoretic (EPD) method and ultrasonic-assisted 
method.
● GO-HA nanocomposite induced the antibacterial and 
cytotoxicity towards bacterial cells.
● GO is often utilized to reinforce the coating mecha-
nical properties.
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Figure 13.  Zone of inhibition of: a) GO-HA against Enterococcus faecalis (A) and Pseudomonas aeruginosa (B) [106]; 
b) 10 wt. % PCL/HA/GO composite against S. aureus and E. coli [107]; c) silicate-based composites against E. coli and S. aureus 
by agar well diffusion method (after 48 h) and d) bar chart of antibacterial activity of silicate-based composites against E. coli and 
S. aureus [108].
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● GO-HA nanocomposite could be a promising can-
didate for antibacterial coating in biomedical devices.
● Future GO-HA studies of antibacterial activities 
towards bacterial cell membranes and inclusion of 
third element in nanocomposite might improve anti-
bacterial properties in nanocomposite.
Future Perspectives
 In this review, we have discussed the properties 
of HA and GO nanoparticles, the combining approach 
of GO-HA nanocomposite as well as its antibacterial 
and toxicity towards biological system. The uniqueness 
properties of GO itself contribute to antibacterial 
activity and at the same time reinforced HA to increase 
their mechanical properties. The successful combining 
GO-HA nanocomposite was proven by many ways 
including wet chemical precipitation method, sol-gel 
method, hydrothermal method electrochemical deposi-
tion method/ electrophoretic (EPD) method and ultra-
sonic-assisted method. The different the method used 
the different the result of application will achieved. 
 In this review, we focused on recent studies con-
cerning the cytotoxicity and antibacterial activity of GO 
and GO-HA composites both in vitro and in vivo. Most 
of the previous studied discovered of biocompatibility 
of HA and GO rather than antibacterial activity and 
cytotoxicity of GO and HA. GO-HA nanocomposite 
induced antibacterial and cytotoxicity activity towards 
bacterial cells. Antibacterial activity and cytotoxicity of 
GO and GO-HA composites has been studied mostly in 
terms in vitro analysis and further in vivo analysis should 
be conducted being considered for clinical applications. 
Coating of implants in bone tissue and for longer period 
is required absolute assessment of in vivo antibacterial 
to establish the application of GO-HA composites in 
biomedical. 
 GO-HA was served as future excellent biologic 
coating implant. The studies on GO-HA nanocomposite 
in term of antibacterial coatings in biomedical field have 
not much been explored. Therefore, future research 
should be concerned on antibacterial mechanism of 
the composites with model bacterial cell membranes 
will provide in depth understanding of the interaction. 
The inclusion of third elements in composites, and 
other synthesis methods may also be exploited in order 
to produce anti-bacterial composites with improved 
properties. 
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